| Application no. and date | 91311583.8 (espacenet) (Federated) (European Patent Register), 19911212 | | Patent/reg. no. and date | DK/EP 0490689, 19950315 | | Publication date | 19920617 | | Priority no. and date | GB 9026998, 19901212 | | EP pub. no. and date |
EP 0490689 19920617 | | Effective date | | | Applicant/owner | GLAXO GROUP LIMITED, Glaxo House, Berkeley Avenue, Greenford, Middlesex UB6 0NN , GB | | Applicant ref. no. | 231493 | | Inventor | Craig, Joanne, c/o Glaxo Group Research Limited, Park Road, Ware, Hertfordshire SG12 0DG , GB,
Crookes, Derek Leslie, c/o Glaxo Group Research Limited, Park Road, Ware, Hertfordshire SG12 0DG , GB,
Skittrall, Stephen John, c/o Glaxo Group Research Limited, Park Road, Ware, Hertfordshire SG12 0DG , GB | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/40, C07D 209/16 | | Title | 3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indol-5-methansulfonamid sulfatsalt (2:1) | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
